COMMUNIQUÉS West-GlobeNewswire

Verrica Announces Late-Breaking Oral Presentation at the 2019 American Academy of Dermatology Annual Meeting
12/02/2019
Results from Two Pivotal Phase 3 Clinical Trials of Lead Candidate VP-102 in the Treatment of Molluscum Contagiosum to be Presented on March 2, 2019 WEST CHESTER, Pa., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Verrica [...]
Amicus Therapeutics to Announce Full-Year 2018 Financial Results on February 28, 2019
12/02/2019
CRANBURY, N.J., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, February 28, 2019 at 8:30 a.m. ET to [...]
Tetra Bio-Pharma Provides Update on its Neuropathic and Chronic Pain Drug Development Program
12/02/2019
ORLEANS, Ontario, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc . (" Tetra " or the " Corporation ") (TSX VENTURE: TBP) (OTCQB: TBPMF), a global leader in cannabinoid-derived drug development and discovery, [...]
BriaCell Appoints Jamieson Bondarenko to its Board of Directors
12/02/2019
BERKELEY, Calif. and VANCOUVER, British Columbia, Feb. 12, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (TSX-V:BCT) (OTCQB:BCTXF) (" BriaCell " or the " Company "), an immuno-oncology focused biotechnology [...]
Emergent BioSolutions Announces Appointment of Seamus Mulligan to its Board of Directors
12/02/2019
GAITHERSBURG, Md., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the appointment of Seamus Mulligan to the company’s Board of Directors effective March 19, 2019. Mr. Mulligan [...]
MediPharm Labs Signs $35 Million Private Label Cannabis Oil Sale Agreement with Option for Additional $13.5 Million
12/02/2019
TORONTO, Feb. 12, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (“MediPharm”) a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased to announce [...]
CorVel Announces Expansion of Stock Repurchase Program
12/02/2019
IRVINE, Calif., Feb. 12, 2019 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), reported that the Company’s Board of Directors has approved a 1,000,000 share expansion to its existing stock repurchase program, [...]
Kamada Reports Financial Results for Fourth Quarter and Fiscal Year 2018
12/02/2019
Total Revenues for Fiscal 2018 were $114.5 Million, up 11% Over Fiscal 2017; In-line with Recently Provided 2018 Expected Revenues of $113 Million and $115 Million Full-Year Proprietary Products Revenues up 14% Year- [...]
RAMSAY GENERALE DE SANTE : augmentation de capital avec maintien du droit préférentiel de souscription
12/02/2019
COMMUNIQUE DE PRESSE Ramsay Générale de Santé confirme son intention de lancer une augmentation de capital avec maintien du droit préférentiel de souscription Paris, 12 février 2019 - Ramsay Générale de Santé S.A. (« [...]
Transactions in relation to share buyback program
12/02/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Chi-Med Highlights Preliminary Phase II Savolitinib / Imfinzi® Combination Data in Advanced Papillary Renal Cell Carcinoma at 2019 ASCO Genitourinary Cancers Symposium
12/02/2019
LONDON, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announced the availability of preliminary results from the Phase II CALYPSO study of the savolitinib / [...]
Almirall and Dermira Enter into Option and License Agreement for European Rights to Lebrikizumab
12/02/2019
- Almirall acquires option to license rights to develop and commercialize lebrikizumab for atopic dermatitis in Europe - Dermira to receive an option fee of $30 million - Lebrikizumab is an investigational anti-IL-13 [...]
Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) Split Dosing Regimen
12/02/2019
Media Release Copenhagen, Denmark, February 12, 2019 DARZALEX split dosing regimen approved by U.S. FDA Provides healthcare professionals with option to split first DARZALEX infusion over two consecutive days Approval [...]
Sanofi appoints Ameet Nathwani Chief Digital Officer
12/02/2019
Press Release Source: Sanofi (EURONEXT: SAN) (NASDAQ: SNY) Sanofi appoints Ameet Nathwani Chief Digital Officer Ameet Nathwani, M.D., will also continue to serve as Executive Vice-President, Chief Medical Officer Paris [...]
Sanofi nomme Ameet Nathwani au poste de Chief Digital Officer
12/02/2019
Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NASDAQ : SNY) Sanofi nomme Ameet Nathwani au poste de Chief Digital Officer Le Dr Ameet Nathwani continuera d'exercer les fonctions de Vice-Président Exécutif, [...]
Innate Pharma announces appointment of Laure-Hélène Mercier to the Executive Board
12/02/2019
INNATE PHARMA ANNOUNCES APPOINTMENT OF LAURE-HÉLÈNE MERCIER TO THE EXECUTIVE BOARD Appointments of Dr. Mondher Mahjoubi, Chief Executive Officer, and Dr. Yannis Morel, EVP Business Development and Portfolio Strategy, [...]
Innate Pharma annonce la nomination de Laure-Hélène Mercier au Directoire
12/02/2019
INNATE PHARMA ANNONCE LA NOMINATION DE LAURE-HÉLÈNE MERCIER AU DIRECTOIRE Les mandats de membres du Directoire Mondher Mahjoubi, Président du Directoire, et de Yannis Morel, Vice-président Exécutif, Stratégie Produits [...]
Veritas Pharma Announces the Resignation of CEO, Dr. Lui Franciosi
12/02/2019
VANCOUVER, British Columbia, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces the resignation of its President, CEO and Director, Dr [...]
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2019 Ended December 31, 2018 and Provides Conference Call Information
11/02/2019
Conference Call Scheduled for Tuesday, February 12 th at 11:30 AM EST NORTHVALE, N.J., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical [...]

Pages